✕

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Bernstein Analysts See Strategic Discipline Ahead Under New UnitedHealth CEO

With a price target of $377, analysts from the Bernstein SocGen Group reiterated their Outperform rating on UnitedHealth Group Incorporated (NYSE:UNH) on June 4. The analysts outlined the company’s underwriting culture, management team composition, and strategy choices as top considerations for Steve Hemsley, the recently appointed CEO.

Ken Wolter/Shutterstock.com

Bernstein analysts took note of a change in the company’s underwriting culture while highlighting their expectations for the new CEO’s responsibilities. They expect 2026 to be an important year for pricing restraint, with a focus on maintaining margins rather than expanding.

Steve Hemsley, UnitedHealth’s new CEO, has stated that he will immediately concentrate on pricing discipline. This includes predicting financial and care-related behaviors, such as commercial pricing and Medicare Advantage bids. Moreover, Bernstein’s analysts brought up the possibility of a significant strategic choice involving a possible division of UnitedHealth’s UHC and Optum operations.

UnitedHealth Group Incorporated is a renowned US multinational corporation that provides managed healthcare and insurance services. The company operates through four main segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx.

Read More: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds